List your company on Longevity Club — free.

Put your products in front of thousands of active longevity customers.

Claim free listing

Next Sequence Investor

Next Sequence is a venture capital fund focused on supporting globally start-ups from the OpenSynBio ecosystem. Our mission is to contribute to the development of the most disruptive companies who want to enable humanity to face up to its next challenges as a species, from fighting genetically transmitted diseases and pandemics to preventing ageing and climate change.


Invests into

Technology: Biomarker Discovery & Validation
Funding Status: private
Industry: BioPharma AI
Investor Type: Venture Funds
Founded Date: 2021-11-01
Headquarters: New York,New York,United States,North America